B2M overexpression

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

B2M overexpression	Squamous Cell Carcinoma of Head and Neck	B2M overexpression	Squamous Cell Carcinoma of Head and Neck	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
B2M overexpression	Bladder Cancer	B2M overexpression	Bladder Cancer	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3

Associations